295 related articles for article (PubMed ID: 22805601)
1. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
Ignar DM; Goetz AS; Noble KN; Carballo LH; Stroup AE; Fisher JC; Boucheron JA; Brainard TA; Larkin AL; Epperly AH; Shearer TW; Sorensen SD; Speake JD; Hommel JD
J Pharmacol Exp Ther; 2011 Oct; 339(1):24-34. PubMed ID: 21712426
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism.
Giuliano C; Robbins TW; Wille DR; Bullmore ET; Everitt BJ
Psychopharmacology (Berl); 2013 May; 227(1):137-47. PubMed ID: 23299095
[TBL] [Abstract][Full Text] [Related]
4. The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.
Giuliano C; Goodlett CR; Economidou D; García-Pardo MP; Belin D; Robbins TW; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2015 Dec; 40(13):2981-92. PubMed ID: 26044906
[TBL] [Abstract][Full Text] [Related]
5. Opioid system in the medial prefrontal cortex mediates binge-like eating.
Blasio A; Steardo L; Sabino V; Cottone P
Addict Biol; 2014 Jul; 19(4):652-62. PubMed ID: 23346966
[TBL] [Abstract][Full Text] [Related]
6. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.
Cottone P; Sabino V; Steardo L; Zorrilla EP
Neuropsychopharmacology; 2008 Feb; 33(3):524-35. PubMed ID: 17443124
[TBL] [Abstract][Full Text] [Related]
7. Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.
Ziauddeen H; Chamberlain SR; Nathan PJ; Koch A; Maltby K; Bush M; Tao WX; Napolitano A; Skeggs AL; Brooke AC; Cheke L; Clayton NS; Sadaf Farooqi I; O'Rahilly S; Waterworth D; Song K; Hosking L; Richards DB; Fletcher PC; Bullmore ET
Mol Psychiatry; 2013 Dec; 18(12):1287-93. PubMed ID: 23147384
[TBL] [Abstract][Full Text] [Related]
8. Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people.
Cambridge VC; Ziauddeen H; Nathan PJ; Subramaniam N; Dodds C; Chamberlain SR; Koch A; Maltby K; Skeggs AL; Napolitano A; Farooqi IS; Bullmore ET; Fletcher PC
Biol Psychiatry; 2013 May; 73(9):887-94. PubMed ID: 23245760
[TBL] [Abstract][Full Text] [Related]
9. The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.
Kelly E; Mundell SJ; Sava A; Roth AL; Felici A; Maltby K; Nathan PJ; Bullmore ET; Henderson G
Psychopharmacology (Berl); 2015 Jan; 232(1):305-14. PubMed ID: 24973897
[TBL] [Abstract][Full Text] [Related]
10. Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.
Chamberlain SR; Mogg K; Bradley BP; Koch A; Dodds CM; Tao WX; Maltby K; Sarai B; Napolitano A; Richards DB; Bullmore ET; Nathan PJ
Psychopharmacology (Berl); 2012 Dec; 224(4):501-9. PubMed ID: 22752384
[TBL] [Abstract][Full Text] [Related]
11. Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm.
Katsuura Y; Taha SA
Neuroscience; 2014 Mar; 261():144-52. PubMed ID: 24342569
[TBL] [Abstract][Full Text] [Related]
12. The uncompetitive N-methyl-D-aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: role of the nucleus accumbens shell.
Smith KL; Rao RR; Velázquez-Sánchez C; Valenza M; Giuliano C; Everitt BJ; Sabino V; Cottone P
Neuropsychopharmacology; 2015 Mar; 40(5):1163-71. PubMed ID: 25381776
[TBL] [Abstract][Full Text] [Related]
13. The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats.
Ferragud A; Howell AD; Moore CF; Ta TL; Hoener MC; Sabino V; Cottone P
Neuropsychopharmacology; 2017 Jun; 42(7):1458-1470. PubMed ID: 27711047
[TBL] [Abstract][Full Text] [Related]
14. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
15. The Effects of the Monoamine Stabilizer (-)-OSU6162 on Binge-Like Eating and Cue-Controlled Food-Seeking Behavior in Rats.
Feltmann K; Giuliano C; Everitt BJ; Steensland P; Alsiö J
Neuropsychopharmacology; 2018 Feb; 43(3):617-626. PubMed ID: 28895569
[TBL] [Abstract][Full Text] [Related]
16. The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
Ripley TL; Sanchez-Roige S; Bullmore ET; Mugnaini M; Maltby K; Miller SR; Wille DR; Nathan P; Stephens DN
Psychopharmacology (Berl); 2015 Sep; 232(18):3431-41. PubMed ID: 26141191
[TBL] [Abstract][Full Text] [Related]
17. Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: Exploration of a binge-like eating model.
Presby RE; Rotolo RA; Yang JH; Correa M; Salamone JD
Pharmacol Biochem Behav; 2020 Feb; 189():172851. PubMed ID: 31931017
[TBL] [Abstract][Full Text] [Related]
18. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
Ward HG; Simansky KJ
Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist.
Nathan PJ; O'Neill BV; Bush MA; Koch A; Tao WX; Maltby K; Napolitano A; Brooke AC; Skeggs AL; Herman CS; Larkin AL; Ignar DM; Richards DB; Williams PM; Bullmore ET
J Clin Pharmacol; 2012 Apr; 52(4):464-74. PubMed ID: 21610207
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans.
Rabiner EA; Beaver J; Makwana A; Searle G; Long C; Nathan PJ; Newbould RD; Howard J; Miller SR; Bush MA; Hill S; Reiley R; Passchier J; Gunn RN; Matthews PM; Bullmore ET
Mol Psychiatry; 2011 Aug; 16(8):826-35, 785. PubMed ID: 21502953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
